The Role of Immune Markers in Predicting Infectious Complications in Children with Congenital Heart Defects

Degtyareva Elena1, Mwela Bupe Mumba1, Prodeus Andrey2

  • 1Federal State Autonomous Educational Institution of Higher Education "People's Friendship University of Russia" named after Patrice Lumumba, Moscow, Russia.

PubMed

Insights

Congenital heart defects (CHDs) are linked to immune deficiencies, increasing infection risk. T-cell receptor excision circles (TRECs) screening can predict complications in infants with CHDs, aiding in preoperative preparation and reducing mortality.

Area of Science:

  • Immunology
  • Pediatrics
  • Cardiology

Background:

  • Congenital heart defects (CHDs) are frequently associated with immunological deficiencies, leading to severe infectious complications.
  • Primary and secondary immunodeficiencies, including genetic syndromes, are observed in CHDs, with critical and cyanotic CHDs showing more severe immune dysfunction.
  • T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) are valuable biomarkers for assessing T- and B-cell maturation, crucial for neonatal screening.

Purpose of the Study:

  • To review existing literature on immunological deficiency in CHDs and its impact on infectious complications.
  • To evaluate the utility of TREC and KREC quantification in identifying immune defects in infants with CHDs.
  • To assess the prognostic value of TREC levels for predicting postoperative complications and mortality in pediatric cardiac surgery patients.

Main Methods:

  • Literature review of studies on CHD and immunodeficiency over the past two decades.
  • Analysis of TREC and KREC levels in neonatal screening and in infants with CHDs.
  • Comparison of infectious complication rates between children with reduced and normal TREC levels.

Main Results:

  • A significant percentage of children with CHDs exhibit immunological disorders, particularly those with syndromic, critical, or cyanotic forms.
  • Reduced TREC levels were detected in 23.5% of studied children with CHD, including all syndromic cases.
  • Children with reduced TREC levels experienced significantly higher rates of postoperative infectious complications (36% vs. 3.6%).

Conclusions:

  • TREC and KREC screening holds prognostic value for identifying infants with CHDs at high risk for immunological dysfunction.
  • Early identification of immune defects through TREC/KREC analysis can guide targeted preoperative preparation.
  • Implementing TREC/KREC screening can potentially reduce postoperative complications and mortality in pediatric patients with CHDs.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...